Incumbency footprint / loaded awards
NATIONWIDE PHARMACEUTICAL LLC
Source set: USASpending · As of 2026-11-10. Coverage is limited to loaded award records.
UEI as published: T6EELTPV6GR4
Active-award and obligated rollups are withheld: the agent-written rollup has no covered period or n field. A full federal footprint is not verified.
Loaded award records
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| NATIONWIDE PHARMACEUTICAL LLC36C77622P0048 ↗ | Department of Veterans Affairs | $1,210,532.46 | 2026-11-21Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C77622P0048_3600_-NONE-_-NONE-As of 2025-11-20 |
| NATIONWIDE PHARMACEUTICAL LLC19AQMM23P0306 ↗ | Department of State | $887,868.00 | 2027-03-03Period of performance current end date (USASpending) | USASpendingCONT_AWD_19AQMM23P0306_1900_-NONE-_-NONE-As of 2026-02-11 |
| NATIONWIDE PHARMACEUTICAL LLC36C25622P0585 ↗ | Department of Veterans Affairs | $511,908.60 | 2027-03-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C25622P0585_3600_-NONE-_-NONE-As of 2026-08-24 |
| NATIONWIDE PHARMACEUTICAL LLC75F40125P00074 ↗ | Department of Health and Human Services | $322,440.00 | 2027-04-30Period of performance current end date (USASpending) | USASpendingCONT_AWD_75F40125P00074_7524_-NONE-_-NONE-As of 2026-09-25 |
| NATIONWIDE PHARMACEUTICAL LLC36C24621P1166 ↗ | Department of Veterans Affairs | $302,852.00 | 2026-12-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C24621P1166_3600_-NONE-_-NONE-As of 2026-06-30 |
| NATIONWIDE PHARMACEUTICAL LLC75D30124C19636 ↗ | Department of Health and Human Services | $284,878.00 | 2027-08-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_75D30124C19636_7523_-NONE-_-NONE-As of 2026-08-24 |
Upcoming source end dates
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| NATIONWIDE PHARMACEUTICAL LLC36C77622P0048 ↗ | Department of Veterans Affairs | $1,210,532.46 | 2026-11-21Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C77622P0048_3600_-NONE-_-NONE-As of 2025-11-20 |
| NATIONWIDE PHARMACEUTICAL LLC19AQMM23P0306 ↗ | Department of State | $887,868.00 | 2027-03-03Period of performance current end date (USASpending) | USASpendingCONT_AWD_19AQMM23P0306_1900_-NONE-_-NONE-As of 2026-02-11 |
| NATIONWIDE PHARMACEUTICAL LLC36C25622P0585 ↗ | Department of Veterans Affairs | $511,908.60 | 2027-03-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C25622P0585_3600_-NONE-_-NONE-As of 2026-08-24 |
| NATIONWIDE PHARMACEUTICAL LLC75F40125P00074 ↗ | Department of Health and Human Services | $322,440.00 | 2027-04-30Period of performance current end date (USASpending) | USASpendingCONT_AWD_75F40125P00074_7524_-NONE-_-NONE-As of 2026-09-25 |
| NATIONWIDE PHARMACEUTICAL LLC36C24621P1166 ↗ | Department of Veterans Affairs | $302,852.00 | 2026-12-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_36C24621P1166_3600_-NONE-_-NONE-As of 2026-06-30 |
| NATIONWIDE PHARMACEUTICAL LLC75D30124C19636 ↗ | Department of Health and Human Services | $284,878.00 | 2027-08-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_75D30124C19636_7523_-NONE-_-NONE-As of 2026-08-24 |
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.